Product Information
HYDROXYZINE 10 MG/5 ML SYRUP is a generic product labeled by Chartwell RX LLC, priced at $0.1132 per ML under NDC 62135075047. Its NADAC has been published 101 times since Apr 17, 2024.
FDA first approved this application on Apr 12, 1982. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135075047
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA087294FDA Approved
4/12/1982
TE Code
AA
On Market Since
4/12/1982
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE 10 MG/5 ML SYRUP has been published 101 times since Apr 17, 2024, and over the history we have for it it has declined 53.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1132 per ML |
|---|---|
| All-time high | $0.2418 (May 1, 2024) |
| All-time low | $0.1089 (Aug 19, 2026) |
| 52-week high | $0.1609 |
| 52-week low | $0.1089 |
| Median price | $0.1520 |
| Average price | $0.1491 |
| Largest weekly change | -31.2% (Nov 20, 2024) |
| Weeks tracked | 101 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HYDROXYZINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HYDROXYZINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROXYZINE 10 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE 10 MG/5 ML SYRUP, manufactured by Chartwell RX LLC, is $0.1132 per ML (NDC 62135075047), effective Sep 30, 2026.
How has the price of HYDROXYZINE 10 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE 10 MG/5 ML SYRUP has declined 53.2%. It has been tracked across 101 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE 10 MG/5 ML SYRUP?
Since Apr 17, 2024, the NADAC for HYDROXYZINE 10 MG/5 ML SYRUP has ranged from a low of $0.1089 (Aug 19, 2026) to a high of $0.2418 (May 1, 2024), with a median of $0.1520 per ML.
Are there cheaper alternatives to HYDROXYZINE 10 MG/5 ML SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of HYDROXYZINE 10 MG/5 ML SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROXYZINE 10 MG/5 ML SYRUP?
HYDROXYZINE 10 MG/5 ML SYRUP (NDC 62135075047) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.